ADVERTORIAL

Treatment Option For Amyloidosis

by Michael in Uncategorized

VYNDAMAX® (tafamidis) can help those living with ATTR-CM live longer with fewer heart-related hospital visits

At month 30 in a clinical trial of people with either wild-type or hereditary ATTR-CM, VYNDAMAX was proven to significantly reduce death and the number of heart-related hospitalizations in patients with ATTR-CM compared to those who did not take VYNDAMAX (placebo group).

The clinical studies of VYNDAQEL® (tafamidis meglumine) supported the approval of VYNDAMAX, which contains the same active ingredient.

VYNDAMAX helped more people live longer

Survival rate at month 30

In a clinical trial, VYNDAMAX was proven to significantly reduce death and the number of heart-related hospitalizations in patients with ATTR-CM. Patients in the VYNDAMAX group lived longer than those in the placebo group.

People who took VYNDAMAX had fewer heart-related hospitalizations

VYNDAMAX was proven to lower the risk of heart-related hospitalizations by 32% compared with placebo.

Keep in mind

It’s important to remember that even if you don’t feel VYNDAMAX working, always tell your doctor how you are feeling. Be reassured that VYNDAMAX has been proven to help adults with ATTR-CM live longer with fewer heart-related hospitalizations.

How was health-related quality of life measured in patients taking VYNDAMAX?

The Kansas City Cardiomyopathy Questionnaire

The Kansas City Cardiomyopathy Questionnaire (KCCQ) is a 23-question survey that evaluates health-related quality of life. In the same clinical trial, people on VYNDAMAX scored better on a number of health measures at month 30 compared with those not taking VYNDAMAX (placebo group).*

∗Patients in the VYNDAMAX and placebo groups had worse KCCQ overall summary scores at month 30 than at the start of the study.

Sign up to learn more about how VYNDAMAX may help manage ATTR-CM.

THIS IS AN ADVERTISEMENT AND NOT AN ACTUAL NEWS ARTICLE, BLOG, OR CONSUMER PROTECTION UPDATE

Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This information is not intended to be a substitute or replacement for any medical treatment. Please seek the advice of a healthcare professional for your specific health concerns. Individual results may vary.

Marketing Disclosure: This website is a market place. As such you should know that the owner has a monetary connection to the product and services advertised on the site. The owner receives payment whenever a qualified lead is referred but that is the extent of it.

Advertising Disclosure: This website and the products & services referred to on the site are advertising marketplaces. This website is an advertisement and not a news publication. Any photographs of persons used on this site are models. The owner of this site and of the products and services referred to on this site only provides a service where consumers can obtain and compare.